By Amélie Boulais, Head of Market Entry Strategy and Piergiuseppe Nestola, Global Vaccine Technology Consultant, Sartorius
At the start of any virus outbreak or pandemic, the imperative is to accelerate vaccine development without sacrificing safety or efficacy. In other words, how to create ‘success at speed.’ Vaccine developers and manufacturers grapple with numerous questions and uncertainties around expedited development, such as meeting regulatory requirements, vaccine efficacy, and production capacities.
This leads to the more fundamental decision to select the best-suited strategy for vaccine development, i.e., the selection of a vaccine modality.
In a pandemic, speed to market is as critical as safety and efficacy. Sartorius brought their top minds in vaccine manufacturing together and discussed best practices to accelerate processes from vaccine development to distribution. Success at Speed is a collection of articles documenting each step in the journey and how technology and partnerships make the difference in getting medicines to patients when they need them most. Download the eBook now.